Collectively, our findings demonstrate the presence of these proteins in resistant breast cancer EVs and resistant leukemic EVs and may propose a role in regulating the transfer and insertion of P-gp into recipient cells and /or be the consequence of a selective packaging mechanism common to both types of drug-induced cancer cells. Here, PGP is linked to breast carcinoma.